HIGHLIGHTS
- who: Geir Hetland and colleagues from the Department of Immunology and Transfusion Medicine, Oslo University Hospital Ullevål, Oslo have published the research: Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects, in the Journal: Vaccines 2022,2022, 10, 1267 Vaccines 10, x FOR PEER REVIEW of 28/06/2022
- what: This study examines whether key markers for NETosis such as H3-NETs and calprotectin as well as syndecan-1 for endotheliopathy can be used as prognostic factors to predict the severity of complications associated with ChAdOx1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.